COMBINATIONS FOR THE TREATMENT OF DISEASES ASSOCIATED WITH CELL PROLIFERATION, MIGRATION OR APOPTOTIS OF MYELOMA CELLS OR ANGIOGENESIS

摘要

The application describes a pharmaceutical combination for treating diseases associated with cell proliferation, migration or apoptosis of myeloma cells or with angiogenesis. The application also describes a method of treating these diseases, which consists in the joint administration of effective amounts of specific active ingredients and / or joint treatment using radiotherapy, in a ratio that provides an additive or synergistic effect, as well as in the combined use of these specific compounds and / or radiotherapy, and a method for preparing appropriate pharmaceutical combination preparations.